Neuberger Berman Group
BIVV

Neuberger Berman Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Neuberger Berman Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-254,882
Closed -$13.7M – 1813
2017
Q4 		$13.7M Buy
254,882
+245,010
+2,482% +$13.4M 0.02% 720
2017
Q3 		$563K Buy
9,872
+3,124
+46% +$183K ﹤0.01% 1278
2017
Q2 		$406K Sell
6,748
-1,636
-20% -$93.2K ﹤0.01% 1350
2017
Q1 		$457K Buy
+8,384
New +$413K ﹤0.01% 1328

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Neuberger Berman Group's BIVV Position: Q1 2018 in Review

Neuberger Berman Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 254,882 shares — an estimated $13.7M sold.

Neuberger Berman Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $13.7M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Neuberger Berman Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Neuberger Berman Group sold 254,882 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $13.7M.
  • Neuberger Berman Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Neuberger Berman Group's Bioverativ Inc. Common Stock position peaked at $13.7M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Neuberger Berman Group's 13F filing for Q1 2018, filed 8 May 2018.